# MRPS33

## Overview
MRPS33 is a gene that encodes the mitochondrial ribosomal protein S33, a crucial component of the small 28S subunit of the mitochondrial ribosome. This protein is integral to the process of mitochondrial protein synthesis, facilitating the translation of mitochondrial mRNA into proteins essential for mitochondrial function and energy production (Li2020Quantitative; Gallenga2021Molecular). As part of the mitochondrial ribosome, MRPS33 plays a vital role in the synthesis of proteins that are key components of the electron transport chain, thereby influencing oxidative phosphorylation and ATP production (Li2020Quantitative). Beyond its primary role in mitochondrial translation, MRPS33 is implicated in various cellular processes, including protein import into mitochondria and potential extramitochondrial functions, as suggested by its interactions with proteins in the cytoplasm and nucleus (Pecorelli2013Genes; Revathi2021Expression). Dysregulation of MRPS33 has been linked to diseases such as retinitis pigmentosa and epithelial ovarian carcinoma, highlighting its clinical significance (Li2020Quantitative; Gallenga2021Molecular).

## Function
MRPS33 encodes a protein that is a component of the small 28S subunit of the mitochondrial ribosome. This protein plays a crucial role in mitochondrial protein synthesis by facilitating the translation of mitochondrial mRNA into functional proteins, which is essential for maintaining normal mitochondrial function and energy production (Li2020Quantitative; Gallenga2021Molecular). The mitochondrial ribosome, where MRPS33 is active, is responsible for the translation of mRNAs encoded by mitochondrial DNA, which includes key components of the electron transport chain (ETC) complexes. These complexes are vital for oxidative phosphorylation and ATP production, impacting cellular metabolism and energy homeostasis (Li2020Quantitative).

In healthy human cells, MRPS33 is involved in maintaining mitochondrial structure and organization, particularly in protein import into mitochondria (Pecorelli2013Genes). The protein's activity is crucial for the proper functioning of the mitochondrial translation machinery, which is necessary for the synthesis of proteins that are integral to mitochondrial energy metabolism and cellular function (Gallenga2021Molecular). Dysregulation of MRPS33 can lead to impaired mitochondrial protein synthesis, contributing to cellular dysfunction and diseases such as retinitis pigmentosa and epithelial ovarian carcinoma (Li2020Quantitative; Gallenga2021Molecular).

## Clinical Significance
MRPS33 is associated with DFNB13, a form of non-syndromic hearing loss. However, the specific mechanisms by which mutations or alterations in MRPS33 expression lead to this condition are not well-documented (PerezMartinez2008Protein). The gene is part of a broader group of mitochondrial ribosomal proteins (MRPs) that have been implicated in various human diseases, including cancer, mitochondrial syndromes, cardiovascular diseases, and Parkinson's disease. MRPS proteins, including MRPS33, are involved in diverse cellular processes and signaling pathways, such as the spliceosome and MAPK signaling, which may contribute to their roles in disease (Revathi2021Expression).

While specific diseases directly caused by MRPS33 mutations are not extensively detailed, the protein's involvement in mitochondrial function suggests that disruptions could impact cellular energy metabolism and apoptosis regulation, potentially contributing to mitochondrial disorders and neurodegenerative diseases (Revathi2021Expression). The adaptive evolution of MRPS33 and its orthologs across species indicates its essential role in maintaining mitochondrial ribosome function, which, when altered, could lead to various pathologies (Smits2007Reconstructing).

## Interactions
MRPS33 is a component of the mitochondrial ribosomal small subunit and is involved in mitochondrial protein synthesis. The study of MRPS33 has revealed its participation in a network of protein-protein interactions (PPIs) that suggest potential roles in cellular processes beyond its primary function in the mitochondria. MRPS33 was included in a protein interactome network constructed using the ANAT general network tool, which identified both known and novel PPIs. This network analysis indicated that MRPS33 interacts with proteins located in the cytoplasm and nucleus, suggesting possible extramitochondrial functions (Revathi2021Expression).

The study employed GST pull-down assays and nLC/MS analysis to validate these interactions, although specific physical interactions of MRPS33 with other proteins or nucleic acids were not detailed in the provided excerpts (Revathi2021Expression). Pathway enrichment analysis implicated MRPS33 in the spliceosome pathway, indicating a potential role in RNA processing or modification (Revathi2021Expression). Despite these findings, the precise nature of MRPS33's interactions with other proteins or nucleic acids remains to be fully elucidated, as specific interactions were not detailed in the available context.


## References


[1. (Pecorelli2013Genes) Alessandra Pecorelli, Guido Leoni, Franco Cervellati, Raffaella Canali, Cinzia Signorini, Silvia Leoncini, Alessio Cortelazzo, Claudio De Felice, Lucia Ciccoli, Joussef Hayek, and Giuseppe Valacchi. Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of rett syndrome patients. Mediators of Inflammation, 2013:1–18, 2013. URL: http://dx.doi.org/10.1155/2013/137629, doi:10.1155/2013/137629. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1155/2013/137629)

[2. (PerezMartinez2008Protein) Xochitl Perez-Martinez, Soledad Funes, Yolanda Camacho-Villasana, Sanna Marjavaara, Faviola Tavares-Carreon, and Miguel Shingu-Vazquez. Protein synthesis and assembly in mitochondrial disorders. Current Topics in Medicinal Chemistry, 8(15):1335–1350, October 2008. URL: http://dx.doi.org/10.2174/156802608786141124, doi:10.2174/156802608786141124. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.2174/156802608786141124)

[3. (Li2020Quantitative) Na Li, Huanni Li, Ya Wang, Lanqin Cao, and Xianquan Zhan. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3p medicine. EPMA Journal, 11(4):661–694, October 2020. URL: http://dx.doi.org/10.1007/s13167-020-00224-z, doi:10.1007/s13167-020-00224-z. This article has 23 citations.](https://doi.org/10.1007/s13167-020-00224-z)

[4. (Revathi2021Expression) Oviya Revathi Paramasivam, Gopal Gopisetty, Jayavelu Subramani, and Rajkumar Thangarajan. Expression and affinity purification of recombinant mammalian mitochondrial ribosomal small subunit (mrps) proteins and protein–protein interaction analysis indicate putative role in tumourigenic cellular processes. The Journal of Biochemistry, 169(6):675–692, January 2021. URL: http://dx.doi.org/10.1093/jb/mvab004, doi:10.1093/jb/mvab004. This article has 7 citations.](https://doi.org/10.1093/jb/mvab004)

[5. (Gallenga2021Molecular) Carla Enrica Gallenga, Maria Lonardi, Sofia Pacetti, Sara Silvia Violanti, Paolo Tassinari, Francesco Di Virgilio, Mauro Tognon, and Paolo Perri. Molecular mechanisms related to oxidative stress in retinitis pigmentosa. Antioxidants, 10(6):848, May 2021. URL: http://dx.doi.org/10.3390/antiox10060848, doi:10.3390/antiox10060848. This article has 53 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/antiox10060848)

[6. (Smits2007Reconstructing) Paulien Smits, Jan A. M. Smeitink, Lambert P. van den Heuvel, Martijn A. Huynen, and Thijs J. G. Ettema. Reconstructing the evolution of the mitochondrial ribosomal proteome. Nucleic Acids Research, 35(14):4686–4703, June 2007. URL: http://dx.doi.org/10.1093/nar/gkm441, doi:10.1093/nar/gkm441. This article has 156 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkm441)